The RING ubiquitin E3 RNF114 interacts with A20 and modulates NF-κB activity and T-cell activation

Accurate regulation of nuclear factor-κB (NF-κB) activity is crucial to prevent a variety of disorders including immune and inflammatory diseases. Active NF-κB promotes IκBα and A20 expression, important negative regulatory molecules that control the NF-κB response. In this study, using two-hybrid screening we identify the RING-type zinc-finger protein 114 (RNF114) as an A20-interacting factor. RNF114 interacts with A20 in T cells and modulates A20 ubiquitylation. RNF114 acts as negative regulator of NF-κB-dependent transcription, not only by stabilizing the A20 protein but also IκBα. Importantly, we demonstrate that in T cells, the effect of RNF114 is linked to the modulation of T-cell activation and apoptosis but is independent of cell cycle regulation. Altogether, our data indicate that RNF114 is a new partner of A2O involved in the regulation of NF-κB activity that contributes to the control of signaling pathways modulating T cell-mediated immune response.

[1]  Lin-Feng Chen,et al.  NF-κB Is Essential for Induction of CYLD, the Negative Regulator of NF-κB , 2004, Journal of Biological Chemistry.

[2]  S. Ghosh,et al.  The NF-kappaB family of transcription factors and its regulation. , 2009, Cold Spring Harbor perspectives in biology.

[3]  Qiaqing Wu,et al.  Cloning and expression analysis of a novel mouse zinc finger protein gene Znf313 abundantly expressed in testis. , 2007, Journal of biochemistry and molecular biology.

[4]  J. Baik,et al.  ZNF313 is a novel cell cycle activator with an E3 ligase activity inhibiting cellular senescence by destabilizing p21WAF1 , 2013, Cell Death and Differentiation.

[5]  Rudi Beyaert,et al.  Expression, biological activities and mechanisms of action of A20 (TNFAIP3). , 2010, Biochemical pharmacology.

[6]  T. Gilmore,et al.  Introduction to NF-kappaB: players, pathways, perspectives. , 2006, Oncogene.

[7]  N. Perkins The Rel/NF-kappa B family: friend and foe. , 2000, Trends in biochemical sciences.

[8]  R. Hay,et al.  Nuclear retention of IkappaBalpha protects it from signal-induced degradation and inhibits nuclear factor kappaB transcriptional activation. , 1999, The Journal of biological chemistry.

[9]  Christian Gieger,et al.  Genome-wide association analysis identifies three psoriasis susceptibility loci , 2010, Nature Genetics.

[10]  M. Karin,et al.  NF‐κB and the link between inflammation and cancer , 2012, Immunological reviews.

[11]  Noula Shembade,et al.  Essential role for TAX1BP1 in the termination of TNF-alpha-, IL-1- and LPS-mediated NF-kappaB and JNK signaling. , 2007, The EMBO journal.

[12]  D. Payan,et al.  A Novel E3 Ubiquitin Ligase TRAC-1 Positively Regulates T Cell Activation , 2005, The Journal of Immunology.

[13]  R. Contreras,et al.  The Zinc Finger Protein A20 Inhibits TNF-induced NF-κB–dependent Gene Expression by Interfering with an RIP- or TRAF2-mediated Transactivation Signal and Directly Binds to a Novel NF-κB–inhibiting Protein ABIN , 1999, The Journal of cell biology.

[14]  N. Copeland,et al.  The E3 ligase Itch negatively regulates inflammatory signaling pathways by controlling the function of the ubiquitin-editing enzyme A20 , 2008, Nature Immunology.

[15]  N. Perkins The Rel/NF-κB family: friend and foe , 2000 .

[16]  N. Perkins,et al.  Good cop, bad cop: the different faces of NF-κB , 2006, Cell Death and Differentiation.

[17]  M. Tatham,et al.  Detection of protein SUMOylation in vivo , 2009, Nature Protocols.

[18]  Lin-Feng Chen,et al.  NF-kappaB is essential for induction of CYLD, the negative regulator of NF-kappaB: evidence for a novel inducible autoregulatory feedback pathway. , 2004, The Journal of biological chemistry.

[19]  G. van Loo,et al.  Genetic relationships between A20/TNFAIP3, chronic inflammation and autoimmune disease. , 2011, Biochemical Society transactions.

[20]  N. Perkins,et al.  Good cop, bad cop: the different faces of NF-kappaB. , 2006, Cell death and differentiation.

[21]  A. Ma,et al.  Failure to regulate TNF-induced NF-kappaB and cell death responses in A20-deficient mice. , 2000, Science.

[22]  Noula Shembade,et al.  Regulation of NF-κB signaling by the A20 deubiquitinase , 2012, Cellular and Molecular Immunology.

[23]  V. Lang,et al.  Fyn membrane localization is necessary to induce the constitutive tyrosine phosphorylation of Sam68 in the nucleus of T lymphocytes. , 1999, Journal of immunology.

[24]  P. Marynen,et al.  T cell antigen receptor stimulation induces MALT1 paracaspase–mediated cleavage of the NF-κB inhibitor A20 , 2008, Nature Immunology.

[25]  Matthew T Wheeler,et al.  The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses , 2004, Nature Immunology.

[26]  V. Dixit,et al.  14-3-3 Proteins Associate with A20 in an Isoform-specific Manner and Function Both as Chaperone and Adapter Molecules* , 1996, The Journal of Biological Chemistry.

[27]  Richard C Trembath,et al.  Functional analysis of the RNF114 psoriasis susceptibility gene implicates innate immune responses to double-stranded RNA in disease pathogenesis. , 2011, Human molecular genetics.

[28]  M. Bijlmakers,et al.  T-cell regulator RNF125/TRAC-1 belongs to a novel family of ubiquitin ligases with zinc fingers and a ubiquitin-binding domain. , 2008, The Biochemical journal.

[29]  V. Lang,et al.  Identification of the NF-κB inhibitor A20 as a key regulator for human adipogenesis , 2013, Cell Death and Disease.

[30]  Pui-Yan Kwok,et al.  Genomewide Scan Reveals Association of Psoriasis with IL-23 and NF-κB Pathways , 2008, Nature Genetics.

[31]  Noula Shembade,et al.  Essential role for TAX1BP1 in the termination of TNF‐α‐, IL‐1‐ and LPS‐mediated NF‐κB and JNK signaling , 2007 .

[32]  R. Beyaert,et al.  A20: Central Gatekeeper in Inflammation and Immunity* , 2009, Journal of Biological Chemistry.

[33]  G. van Loo,et al.  The ubiquitin-editing enzyme A20 (TNFAIP3) is a central regulator of immunopathology. , 2009, Trends in immunology.

[34]  R. Beyaert,et al.  A20 and A20-binding proteins as cellular inhibitors of nuclear factor-kappa B-dependent gene expression and apoptosis. , 2000, Biochemical pharmacology.

[35]  D. Pennington,et al.  Regulation of human bone marrow stromal cell proliferation and differentiation capacity by glucocorticoid receptor and AP-1 crosstalk , 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[36]  M. Schmitz,et al.  Autoregulatory feedback loops terminating the NF-kappaB response. , 2009, Trends in biochemical sciences.

[37]  D. Thomas,et al.  Identification of lysine residues required for signal-induced ubiquitination and degradation of I kappa B-alpha in vivo. , 1996, Oncogene.

[38]  R. Contreras,et al.  A20, an inhibitor of cell death, self‐associates by its zinc finger domain , 1996, FEBS letters.

[39]  Jill K Thompson,et al.  Nuclear Retention of IκBα Protects It from Signal-induced Degradation and Inhibits Nuclear Factor κB Transcriptional Activation* , 1999, The Journal of Biological Chemistry.

[40]  Noula Shembade,et al.  The ubiquitin‐editing enzyme A20 requires RNF11 to downregulate NF‐κB signalling , 2009, The EMBO journal.